|Dozierende||Gunter Festel (email@example.com, BeurteilerIn)|
|Inhalt||Lifescience Venturing is a guideline for those concerned with the creation, management and support of early stage companies in the lifescience industry (e.g. medical technology, molecular biology, biochemistry, biophysics, bioinformatics or immunology sectors).
The course is structured in 5 different parts over two days whereby each part is 90 minutes long. The course will cover all important aspects of founding and building up a start-up company from the planning phase to selling the company.
• Part 1 (start-up companies and business plans) provides an overview on the characteristics and importance of start-ups in innovation processes and how to create a business plan.
• Part 2 (founding and building up a start-up) deals with the aspects of founding and building up a start-up from planning basic decisions, like legal form and location, to building up the organisation.
• Part 3 (financial planning and capital acquisition) describes the financial planning process and the capital acquisition process including capital needs and financial sources.
• Part 4 (company evaluation methods) shows how companies are evaluated and especially the challenges and approaches for the evaluation of early-stage start-ups.
• Part 5 (exit strategy and exit execution) focuses on the development and execution of an exit strategy, such as the trade sale of the company or an IPO.
Working in groups, students will practice core elements of a business plan, financing, holding negotiations with investors including a due diligence and corporate valuation. As preparation for the group work, the students have to read 1 or 2 pre-readings for each part of the course.
|Lernziele||The special focus is on practice oriented aspects, such as financing and negotiation strategies, using practice examples from the lifescience industry. Aim is that the students will acquire the competence necessary to found and successfully build up their own company. Through a clear thematic structure, practise related recommendations and real case studies, participants will obtain a fast and comprehensive insight into this specific topic.|
|Literatur||- Copeland M.V., Malik O. (2006): How to build a bulletproof start-up, Business 2.0, Time Inc., New York
- Holaday J.W., Meltzer S.L., McCormick, J.T. (2003): Strategies for attracting angel investors, Journal of Commercial Biotechnology, Vol. 9, No. 2, January 2003, p. 129-133
- Frei P., Lelux B. (2004): Valuation - what you need to know, Nature Biotechnology, Vol. 22, No. 8, August 2004, p. 1049-1051
|Weblink||Weblink to ADAM|
|Teilnahmebedingungen||There are no preferable conditions for a participation in the course.|
|Anmeldung zur Lehrveranstaltung||As the course is restricted to 30 students, please enrol by email to Gunter Festel until February 20th, 2020. First come, first served!
If you get admitted, please enrol in MOnA. Enrolment = Registration for the exam!
|Einsatz digitaler Medien||kein spezifischer Einsatz|
|Datum||09.05.2020 – 16.05.2020|
|Samstag 09.05.2020||10.15-18.30 Uhr||Wirtschaftswissenschaftliche Fakultät, Seminarraum S15 HG.31|
|Samstag 16.05.2020||10.15-18.30 Uhr||Wirtschaftswissenschaftliche Fakultät, Seminarraum S15 HG.31|
Modul: Wahlbereich (Masterstudium: Wirtschaftswissenschaften)
|Hinweise zur Leistungsüberprüfung||A multiple choice test as performance assessment is offered in june. Credit points will only be assigned if the participant attends all course days and passes the performance assessment.
|An-/Abmeldung zur Leistungsüberprüfung||Anmelden: Belegen; Abmelden: Studiendekanat|
|Wiederholtes Belegen||beliebig wiederholbar|
|Zuständige Fakultät||Wirtschaftswissenschaftliche Fakultät / WWZ, firstname.lastname@example.org|
|Anbietende Organisationseinheit||Wirtschaftswissenschaftliche Fakultät / WWZ|